Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$17.33
neg -0.38
-2.10%
Today's Range: 17.15 - 17.88 | ENDP Avg Daily Volume: 9,836,600
Last Update: 07/26/16 - 3:53 PM EDT
Volume: 3,403,887
YTD Performance: -71.07%
Open: $17.59
Previous Close: $17.71
52 Week Range: $12.56 - $88.54
Oustanding Shares: 222,661,344
Market Cap: 3,896,573,520
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 7
Moderate Buy 1 1 1 1
Hold 11 11 10 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 0
Mean Rec. 2.35 2.35 2.47 2.06
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 5.15
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
5.15 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-41.05% -79.26% -53.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue 13.60 0.10 0.03
Net Income 0.00 -0.60 0.00
EPS 0.00 0.20 0.00
Earnings for ENDP:
EBITDA 1.01B
Revenue 3.27B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.76 $1.12 $4.55 $4.89
Number of Analysts 10 10 11 10
High Estimate $0.86 $1.25 $4.66 $5.30
Low Estimate $0.72 $0.94 $4.25 $4.06
Prior Year $1.08 $1.02 $4.87 $4.55
Growth Rate (Year over Year) -30.09% 10.10% -6.57% 7.41%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Carleton English

 | Jun 28, 2016 | 3:36 PM EDT

ENDP shares surge on rare good news but asset sales may still be necessary.

By

Real Money

 | Jun 21, 2016 | 12:45 PM EDT

Optimism that the United Kingdom will remain part of the EU was tempered by falling oil prices.

By

The Deal

 | May 28, 2016 | 2:00 PM EDT

Problems with mesh products and high leverage might scare away a potential buyer. 

By

David Katz

 | May 12, 2016 | 8:00 AM EDT

Despite an earnings beat and upbeat outlook, its stock has suffered with other drug makers.

bearishEndo downgraded at RBC

May 6, 2016 | 7:42 AM EDT

ENDP was downgraded from Outperform to Sector Perform, RBC Capital said. $26 price target. Turnaround is going to take longer than expected. 

By

Carleton English

 | May 5, 2016 | 6:48 PM EDT

The specialty pharmaceutical company gave investors a lot of news to digest -- and they fled.

By

James Passeri

 | Feb 29, 2016 | 5:07 PM EST

the Sale of ASTORA Women's Health could bode well for the speciality pharma, as legal woes persist.

By

Bret Jensen

 | Jan 7, 2016 | 12:00 PM EST

Mylan and Endo International look like bargains at current prices.

By

Bret Jensen

 | Dec 24, 2015 | 1:00 PM EST

These biotech/pharma picks could give you a very happy new year.

By

Bret Jensen

 | Nov 20, 2015 | 9:00 AM EST

The company cleared an important hurdle last month.

The stock and bond markets have been as close to being "closed" as they can get while the ...
Since its recovery-rally high at 101 last Thursday, Apple Inc. (AAPL) has given back about...
First off, GILD was an unmitigated disaster, we cut this and ran. this is ugly here,...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.